Jagsonpal Pharmaceuticals Ltd - 507789 - Compliance Certificate For The Half Year Ended On 31-03-2019
Compliance Certificate from STA under regulation 40(10).29-04-2019
29-04-2019
Jagsonpal Pharmaceuticals Ltd - 507789 - Compliance Certificate For The Period Ended 31-03-2019
Compliance Certificate from Share Transfer Agent under regulation 7(3)26-04-2019
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Shareholding for the Period Ended March 31, 2019
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here20-04-2019
Jagsonpal Pharmaceuticals Ltd - 507789 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- R K KAPOORDesignation :- Company Secretary and Compliance Officer11-04-2019
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Closure of Trading Window
In terms of SEBI (Prohibition of Insider Trading) Regulation, 2015 (as amended) and Company's Code of Conduct to regulate, monitor and report trading by designated persons & immediate relatives of Designated Persons and pursuant to the clarification issued by NSE vide Ref No: NSE/CML/2019/11 dated 02.04.2019 on the provisions of Clause 4 of the Schedule B of SEBI (Prohibition of Insider Trading) Regulation, 2015 (as amended), the Trading Window for dealing in securities of Jagsonpal Pharmaceuticals Limited("the Company") shall remain closed for Designated Persons and their immediate relative(s) with immediate effect i.e. April 03, 2019 till the end of 48 hours after the declaration of Audited financial results for the Quarter and year ended 31st March, 2019. The same has been intimated to all the directors, officers and designated employees of the company. The date of Board Meeting for declaration of the financial results of the Company for the Quarter and year ended on 31st March, 2019, will be intimated in due course.03-04-2019
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Inline with SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended, the Board of Directors of the company has adopted the "Code of Conduct for Regulating & Reporting Trading by Designated Persons & their Immediate Relatives and for Fair Disclosure" to come into effect from 01.04.2019 (copy attached herewith).03-04-2019
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Certified True Copies of Publication of Financial Results for the Quarter ended 31st December, 2018 pursuant to Regulation 47 (1) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201514-02-2019
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Un-Audited Financial Results For The Quarter Ended On 31 December, 2018
Pursuant to Regulation 33 (3) (d) read with Regulation 47 (1) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Certified True Copies of publication of Standalone Un-Audited Financial Results for the Quarter ended 31st December, 2018, approved at the meeting of the Board of Directors of the company held on 13th February, 2019 at the registered office of the company. Further, the publication was made in one English and Hindi Newspaper of Business Standard respectively. Kindly take the above on record & oblige.13-02-2019
Jagsonpal Pharmaceuticals Ltd - 507789 - Outcome of Board Meeting
In terms of the provisions of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at their meeting held today, (i.e. Wednesday, the 13th Day of February, 2019) at registered office, have inter-alia, approved and taken on record the following: 1. Un-Audited Standalone Financial Results of the Company for the Quarter ended 31st December, 2018; 2. Limited Review Report for the Quarter ended 31st December, 2018; 3. Other Agenda items. The meeting commenced at 12:00 P.M. and concluded at 02:50 P.M. Kindly take the above on record & oblige.13-02-2019
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Certified True Copies of publication of Notice of the Board Meeting to be held on Wednesday, 13th February, 2019 at Registered Office of the company inter-alia, to consider and approve the Standalone Un-Audited Financial Results for the quarter ended 31st December, 2018 in one English and Hindi Newspaper in Business Standard respectively. This is for your information and records.06-02-2019